Uemura, Yusuke http://orcid.org/0000-0002-2262-1452
,
Ishikawa, Shinji
Takemoto, Kenji
Negishi, Yosuke
Tanaka, Akihito
Takagi, Kensuke
Yoshioka, Naoyuki
Umemoto, Norio
Inoue, Yosuke
Morishima, Itsuro
Shibata, Naoki
Asano, Hiroshi
Ishii, Hideki
Watarai, Masato
Murohara, Toyoaki
Article History
Received: 3 October 2019
Accepted: 15 December 2019
First Online: 6 January 2020
Compliance with ethical standards
:
: H.I. received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Daiichi-Sankyo Pharma Inc., and MSD K. K. T.M. received lecture fees from Bayel Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Pfizer Japan Inc., Sanofi-aventis K. K., and Takeda Pharmaceutical Co., Ltd. T.M. received unrestricted research grant for Department of Cardiology, Nagoya University Graduate School of Medicine from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K. K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K. K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-aventis K. K., Takeda Pharmaceutical Co., Ltd., and Teijin Pharma Ltd.
: This study was performed in accordance with the Declaration of Helsinki, and the research protocol was approved by the ethics committees of research institute (Approval no. 2017–0275). Because of a retrospective cohort study, informed consent from individual patients was waived.